Studies suggest that caffeine has antioxidative and anti-inflammatory properties which may play a role in reducing cancer risk including prostate cancer by suppressing cell proliferation and inducing apoptosis through several oncogenic pathways, including PTEN, PI3 K/Akt, p53, and mTOR pathways [24, 25]. This evidence concerns the gene TP53 and prostate carcinoma.